A 67-year-old man with type 2 diabetes and CKD stage 3 has an eGFR of 42. His HbA1c is 86 mmol/mol. Which glucose-lowering agent should be used with most caution?
-
A
DPP-4 inhibitor (sitagliptin)
-
B
SGLT-2 inhibitor (empagliflozin)
-
C
Metformin at full dose
-
D
GLP-1 receptor agonist (liraglutide)